Cholesterol-lowering statin drugs have always been a source of controversy, but a recent admission from the man who conducted the original research on statins only serves to further tarnish their reputation.
Dr. Rory Collins (Oxford University) has admitted the original research into the possible health risks related to the drug's use concentrated on the way statins affect the heart. The research also endeavored to ascertain if the medication presented any cancer risks, but the possibility of other side effects was ignored.
The shocking news emerged last week when the Sunday Express revealed Collins is now calling for further safety checks and admits he has never even seen the full data on the side effects statins might cause.
But after being a staunch statin supporter for so long, why has Collins suddenly had a change of heart? The Express suggests his decision may have been influenced by events in the US, where thousands of lawsuits have been filed against the best-selling statin, Liptor, which allegedly causes diabetes. You can read more on this story at the Express.
Dr. Rory Collins (Oxford University) has admitted the original research into the possible health risks related to the drug's use concentrated on the way statins affect the heart. The research also endeavored to ascertain if the medication presented any cancer risks, but the possibility of other side effects was ignored.
The shocking news emerged last week when the Sunday Express revealed Collins is now calling for further safety checks and admits he has never even seen the full data on the side effects statins might cause.
But after being a staunch statin supporter for so long, why has Collins suddenly had a change of heart? The Express suggests his decision may have been influenced by events in the US, where thousands of lawsuits have been filed against the best-selling statin, Liptor, which allegedly causes diabetes. You can read more on this story at the Express.